{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:10:53Z","timestamp":1783617053272,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.4158\/ep12256.or","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T21:03:25Z","timestamp":1358802205000},"page":"231-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Management of Hyperglycemia in Diabetic Patients with Hematologic Malignancies During Dexamethasone Therapy"],"prefix":"10.1016","volume":"19","author":[{"given":"R. Gosmanov","family":"Aidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goorha","family":"Salil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelts","family":"Sundae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Limin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP12256.OR_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12256.OR_bb0015","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2337\/dc08-0574","article-title":"Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation","volume":"31","author":"Derr","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12256.OR_bb0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2337\/dc06-2563","article-title":"Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation","volume":"30","author":"Garg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12256.OR_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amjmed.2006.05.070","article-title":"Sliding scale insulin use: myth or insanity?","volume":"120","author":"Umpierrez","year":"2007","journal-title":"Am J Med"},{"key":"10.4158\/EP12256.OR_bb0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4158\/EP08331.RAR","article-title":"Glucocorticoid-induced hyperglycemia","volume":"15","author":"Clore","year":"2009","journal-title":"Endocr Pract"},{"key":"10.4158\/EP12256.OR_bb0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12256.OR_bb0040","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/dc07-0295","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12256.OR_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP09102.RA","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"15","author":"Moghissi","year":"2009","journal-title":"Endocr Pract"},{"key":"10.4158\/EP12256.OR_bb0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cncr.20071","article-title":"Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone\/methotrexate-cytarabine regimen","volume":"100","author":"Weiser","year":"2004","journal-title":"Cancer"},{"key":"10.4158\/EP12256.OR_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cncr.22777","article-title":"Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality","volume":"110","author":"Ali","year":"2007","journal-title":"Cancer"},{"key":"10.4158\/EP12256.OR_bb0060","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2337\/db05-1220","article-title":"Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4","volume":"55","author":"Ranta","year":"2006","journal-title":"Diabetes"},{"key":"10.4158\/EP12256.OR_bb0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-54-1-131","article-title":"Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action","volume":"54","author":"Rizza","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12256.OR_bb0070","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.2337\/diabetes.51.10.2895","article-title":"Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin","volume":"51","author":"Willi","year":"2002","journal-title":"Diabetes"},{"key":"10.4158\/EP12256.OR_bb0075","first-page":"E643","article-title":"In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution","volume":"271","author":"Coderre","year":"1996","journal-title":"Am J Physiol"},{"key":"10.4158\/EP12256.OR_bb0080","first-page":"2621","article-title":"High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men","volume":"81","author":"Matsumoto","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12256.OR_bb0085","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMcp060094","article-title":"Clinical practice. Management of hyperglycemia in the hospital setting","volume":"355","author":"Inzucchi","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20404665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/M353H5X337291H03.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:56:35Z","timestamp":1761515795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20404665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1530891X20404665"],"URL":"https:\/\/doi.org\/10.4158\/ep12256.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Hyperglycemia in Diabetic Patients with Hematologic Malignancies During Dexamethasone Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12256.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}